Diagnostics Firms Poised To Gain From Innovation Tax Credit Program
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics firms stand to benefit most among medical device companies from $1 billion in life sciences innovation tax credits approved earlier this year, according to AdvaMed
You may also be interested in...
Guidance released for $1 billion in tax credits
Beginning June 21, qualifying companies with 250 or fewer employees may apply for the new Therapeutic Discovery Project Program tax credit, assuming their projects "show a reasonable potential" to address unmet medical needs, reduce health care costs or advance cancer research. The application period runs through July 21, 2010. HHS will evaluate applications and the IRS will issue certifications no later than Oct. 29, 2010. Individual tax credits of up to $5 million are available per qualifying firm to cover up to 50% of the cost of qualifying biomedical research in 2009 and 2010. Firms can opt for a grant instead. The Treasury Department and National Institutes of Health jointly announced the 1guidelines on May 21. Authorization for the tax credit was included in the recent health reform law
Senate Reform Bill Includes Tax Credit For Dx, Drug-Delivery Investments
Companies with 250 or fewer employees would be eligible for a 50% tax credit on 2009-2010 investments in certain diagnostics, drug-delivery devices and pharmaceuticals under a provision in the Senate's health care reform bill
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.